Insider trading

Period: 120 months Stock: DYN Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

38 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

38 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

38 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

38 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
38 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
38 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

38 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
14 Mar 2023
Farwell Wildon Chief Medical Officer
Sold, plan not stated
$99.19K 7,441 at 13.33
7.4%
14 Mar 2023
Brumm Joshua T See Remarks
Sold, plan not stated
$97.55K 7,318 at 13.33
2.2%
14 Mar 2023
HIGH SUSANNA GATTI Chief Operating Officer
Sold, plan not stated
$20.78K 1,559 at 13.33
1.4%
14 Mar 2023
Beskrovnaya Oxana Chief Scientific Officer
Sold, plan not stated
$18.88K 1,416 at 13.33
1.6%
14 Mar 2023
Sold, plan not stated
$17.48K 1,311 at 13.33
2.3%
14 Mar 2023
McNeill Jonathan See Remarks
Sold, plan not stated
$16.12K 1,209 at 13.33
1.8%
13 Mar 2023
McNeill Jonathan See Remarks
Sold, plan not stated
$13.00K 1,000 at 13.00
1.5%
18 Jan 2023
McNeill Jonathan See Remarks
Sold, plan not stated
$140.30K 10,000 at 14.03
12.9%
9 Jan 2023
McNeill Jonathan See Remarks
Sold, plan not stated
$348.84K 30,150 at 11.57
30.8%
12 Dec 2022
Bought
$10.00M 934,581 at 10.70
opened
First buy on file
12 Dec 2022
Rhodes Jason P Director · indirect
Bought
$10.00M 934,581 at 10.70
opened
First buy on file
12 Dec 2022
Brumm Joshua T See Remarks
Sold, plan not stated
$36.11K 3,322 at 10.87
1.0%
12 Dec 2022
HIGH SUSANNA GATTI Chief Operating Officer
Sold, plan not stated
$8.16K 751 at 10.87
0.7%
12 Dec 2022
Beskrovnaya Oxana Chief Scientific Officer
Sold, plan not stated
$7.39K 680 at 10.87
0.7%
12 Dec 2022
Farwell Wildon Chief Medical Officer
Sold, plan not stated
$6.83K 628 at 10.87
0.6%
12 Dec 2022
McNeill Jonathan See Remarks
Sold, plan not stated
$5.13K 472 at 10.87
0.5%
12 Dec 2022
Sold, plan not stated
$3.39K 312 at 10.87
0.6%
10 Oct 2022
Brumm Joshua T See Remarks
Sold, plan not stated
$2.44M 195,800 at 12.46
48.9%
7 Oct 2022
Brumm Joshua T See Remarks
Sold, plan not stated
$189.85K 14,200 at 13.37
6.5%
11 Mar 2022
Brumm Joshua T See Remarks
Sold, plan not stated
$29.54K 3,384 at 8.73
1.6%
11 Mar 2022
HIGH SUSANNA GATTI Chief Operating Officer
Sold, plan not stated
$6.68K 765 at 8.73
1.0%
11 Mar 2022
Beskrovnaya Oxana Chief Scientific Officer
Sold, plan not stated
$6.05K 693 at 8.73
1.3%
11 Mar 2022
Farwell Wildon Chief Medical Officer
Sold, plan not stated
$5.59K 640 at 8.73
1.0%
11 Mar 2022
McNeill Jonathan See Remarks
Sold, plan not stated
$4.20K 481 at 8.73
0.8%
11 Mar 2022
Sold, plan not stated
$2.69K 308 at 8.73
1.1%
2 Mar 2022
Farwell Wildon Chief Medical Officer
Sold, plan not stated
$48.08K 5,617 at 8.56
7.8%
23 Sep 2021
HIGH SUSANNA GATTI Chief Operating Officer
Sold, plan not stated
$42.21K 2,451 at 17.22
6.8%
21 Sep 2021
Brumm Joshua T See Remarks
Sold, plan not stated
$73.85K 4,584 at 16.11
4.4%
21 Sep 2021
Beskrovnaya Oxana Chief Scientific Officer
Sold, plan not stated
$13.32K 827 at 16.11
4.4%
21 Sep 2021
McNeill Jonathan See Remarks
Sold, plan not stated
$11.74K 729 at 16.11
2.0%
21 Sep 2021
Sold, plan not stated
$7.93K 492 at 16.11
4.4%
20 Sep 2021
Brumm Joshua T See Remarks
Sold, plan not stated
$53.46K 3,425 at 15.61
3.2%
20 Sep 2021
Beskrovnaya Oxana Chief Scientific Officer
Sold, plan not stated
$9.63K 617 at 15.61
3.2%
20 Sep 2021
McNeill Jonathan See Remarks
Sold, plan not stated
$8.51K 545 at 15.61
1.5%
20 Sep 2021
Sold, plan not stated
$5.73K 367 at 15.61
3.2%
21 Sep 2020
VV Manager II, LLC 10% owner · indirect
Bought 2×
$15.49M 815,000 at 19.00
39.5%
First buy on file
21 Sep 2020
Logos Global Management LP 10% owner · indirect
Bought
$13.30M 700,000 at 19.00
87.0%
First buy on file
21 Sep 2020
RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect
Bought
$12.54M 660,000 at 19.00
30.8%
First buy on file
Showing 1–38 of 38.